Core Points - The company reported a revenue of RMB 259 million for the first half of 2025, representing a year-on-year increase of 1.8% [1] - The total comprehensive income attributable to owners of the company for the first half of 2025 was RMB 12.4 million, compared to RMB 8.5 million in the same period of 2024 [1] - Basic and diluted earnings per share for the first half of 2025 were RMB 0.1014, up from RMB 0.0639 in the first half of 2024 [1] - The board has proposed an interim dividend of HKD 0.15 per share for the six months ending June 30, 2025 [1] Business Strategy - The company continues to adhere to a work tone of seeking progress while maintaining stability, focusing on business improvements centered around profitability [1] - The quality of distribution, agency, and service work for the company's products has significantly improved through the efforts of the company and its joint ventures [1] - The company has achieved a smooth transition and steady development of its offline OTC business and has initiated further reform objectives [1] - The online operation model has become more mature and efficient, contributing to the gradual enhancement of online operational efficiency and effectiveness [1] - Overall operational quality of the company has seen significant improvement [1]